ArticleBMJ open2022

Transplantation Without Overimmunosuppression (TWO) study protocol: a phase 2b randomised controlled single-centre trial of regulatory T cell therapy to facilitate immunosuppression reduction in living donor kidney transplant recipients.

Matthew Oliver Brook et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.